Table of Content

1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION & SCOPE 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.2.2 MARKETS COVERED 33
FIGURE 1 WOMEN’S HEALTH DIAGNOSTICS MARKET 33
1.2.3 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 34
1.4 STAKEHOLDERS 34
1.5 LIMITATIONS 35
1.6 SUMMARY OF CHANGES 35

2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY RESEARCH 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY RESEARCH 38
FIGURE 3 PRIMARY SOURCES 38
2.1.2.1 Key data from primary sources 39
2.1.2.2 Breakdown of primaries 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 40
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION 41
FIGURE 7 MARKET ANALYSIS APPROACH 41
FIGURE 8 TOP-DOWN APPROACH 42
2.3 DATA TRIANGULATION APPROACH 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ESTIMATION 45
2.5 ASSUMPTIONS FOR THE STUDY 45

3 EXECUTIVE SUMMARY 46
FIGURE 10 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION, 2020 VS. 2025 46
FIGURE 11 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2020 VS. 2025 47
FIGURE 12 GEOGRAPHIC SNAPSHOT: WOMEN’S HEALTH DIAGNOSTICS MARKET 47
?

4 PREMIUM INSIGHTS 49
4.1 WOMEN’S HEALTH DIAGNOSTICS MARKET OVERVIEW 49
FIGURE 13 RISING INCIDENCE OF CHRONIC AND LIFESTYLE-RELATED DISORDERS TO DRIVE GROWTH IN THE WOMEN’S HEALTH DIAGNOSTICS MARKET 49
4.2 APAC: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE (2019) 50
FIGURE 14 PREGNANCY TESTING & OVULATION PREDICTION KITS DOMINATED THE APAC PREGNANCY & FERTILITY TESTING MARKET IN 2019 50
4.3 GEOGRAPHIC SNAPSHOT OF THE WOMEN’S HEALTH DIAGNOSTICS MARKET 51
FIGURE 15 THE US COMMANDED THE LARGEST SHARE OF THE WOMEN’S HEALTH DIAGNOSTICS MARKET IN 2019 51
4.4 GEOGRAPHIC MIX: WOMEN’S HEALTH DIAGNOSTICS MARKET 52
FIGURE 16 APAC TO WITNESS THE HIGHEST CAGR DURING THE FORECAST PERIOD 52

5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
TABLE 1 WOMEN’S HEALTH DIAGNOSTICS MARKET: IMPACT ANALYSIS 53
5.2.1 MARKET DRIVERS 54
5.2.1.1 High prevalence of infectious diseases in women 54
5.2.1.2 Rising incidence of chronic and lifestyle-related disorders in women 54
5.2.1.3 Increasing awareness about fertility testing in women and initiatives by government and health organizations 55
5.2.1.4 Increased adoption of POC and rapid diagnostic tests 56
5.2.1.5 Growth in the number of private diagnostic and imaging centers 56
5.2.1.6 Public-private partnerships are expected to enhance infrastructure in diagnostic imaging centers 57
5.2.2 MARKET RESTRAINTS 57
5.2.2.1 High cost of diagnostic imaging systems and procedures 57
5.2.2.2 Shortage of skilled laboratory technicians 57
5.2.3 MARKET OPPORTUNITIES 58
5.2.3.1 Improving healthcare infrastructure in emerging markets 58
5.2.3.2 Growing number of regulatory approvals for immunoassay diagnostic techniques 59
5.2.4 MARKET CHALLENGES 59
5.2.4.1 Stringent regulatory guidelines 59
5.2.4.2 Increasing adoption of refurbished diagnostic imaging systems 60
5.3 COVID-19 IMPACT ON THE WOMEN’S HEALTH DIAGNOSTICS MARKET 60

6 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION 62
6.1 INTRODUCTION 63
TABLE 2 WOMEN’S HEALTH DIAGNOSTICS MARKET: PRODUCT PORTFOLIO ANALYSIS 63
TABLE 3 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 64
?
6.2 BREAST CANCER TESTING 64
TABLE 4 BREAST CANCER TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 65
TABLE 5 BREAST CANCER TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 65
6.2.1 MAMMOGRAPHY 66
6.2.1.1 Rising awareness of early detection of breast cancer to fuel the market growth 66
TABLE 6 MAMMOGRAPHY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 66
6.2.2 BREAST CANCER TUMOR MARKER TESTS 67
6.2.2.1 Increasing number of newly diagnosed breast cancer cases will drive the demand for breast cancer tumor marker tests 67
TABLE 7 BREAST CANCER TUMOR MARKER TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 67
6.2.3 BLOOD CHEMISTRY & BLOOD CELL COUNT TESTS 68
6.2.3.1 Growing need for checking the proper functioning of body organs and preventing the spread of infection to other organs will drive market growth 68
TABLE 8 BLOOD CHEMISTRY & BLOOD CELL COUNT TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 68
6.2.4 BIOPSIES 69
6.2.4.1 Growing incidence of breast cancer and high demand for minimally invasive procedures to augment market growth 69
TABLE 9 BIOPSIES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 69
6.2.5 OTHER BREAST CANCER TESTS 69
TABLE 10 OTHER BREAST CANCER TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 70
6.3 INFECTIOUS DISEASE TESTING 70
TABLE 11 INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 71
TABLE 12 INFECTIOUS DISEASE TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 71
6.3.1 UTI TESTING 72
6.3.1.1 Technological advancements like CT scans and ultrasound increase the need for UTI testing 72
TABLE 13 UTI TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 72
6.3.2 HEPATITIS TESTING 73
6.3.2.1 Dynamic shift from traditional diagnostic procedures to portable tests is expected to propel market growth 73
TABLE 14 HEPATITIS TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 74
6.3.3 TUBERCULOSIS TESTING 74
6.3.3.1 Rising tuberculosis cases in women will drive the demand for infectious disease testing 74
TABLE 15 TUBERCULOSIS TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 75
6.3.4 MRSA TESTING 75
6.3.4.1 Development of rapid MRSA tests will drive the market growth 75
TABLE 16 MRSA TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 76
6.3.5 OTHER INFECTIOUS DISEASE TESTS 76
TABLE 17 OTHER INFECTIOUS DISEASE TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 77
6.4 CERVICAL CANCER TESTING 77
TABLE 18 CERVICAL CANCER TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 78
TABLE 19 CERVICAL CANCER TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 78
6.4.1 HPV TESTING 78
6.4.1.1 Easy availability of advanced tests and growing demand for using Pap/HPV co-testing to support market growth 78
TABLE 20 HPV TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 79
6.4.2 PAP SMEARS 79
6.4.2.1 Rising cervical cancer cases and government initiatives are propelling the growth of the market 79
TABLE 21 PAP SMEARS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 80
6.5 STD TESTING 80
TABLE 22 STD TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 81
TABLE 23 STD TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 81
6.5.1 HIV TESTING 82
6.5.1.1 Increasing government support and technological advancements are major factors driving market growth 82
TABLE 24 HIV TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
6.5.2 CT/NG TESTING 83
6.5.2.1 Technological advancements and rapid testing to drive market growth in this application segment 83
TABLE 25 CT/NG TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 84
6.5.3 OTHER STD TESTS 84
TABLE 26 OTHER STD TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 85
6.6 OSTEOPOROSIS TESTING 85
TABLE 27 OSTEOPOROSIS TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 86
TABLE 28 OSTEOPOROSIS TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 86
6.6.1 IN VITRO BLOOD TESTS 86
6.6.1.1 Growing risk of osteoporosis in women during menopause to drive the demand for in vitro blood tests 86
TABLE 29 IN VITRO BLOOD TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 87
6.6.2 BONE DENSITOMETRY 87
6.6.2.1 Growing aging population and high prevalence of osteoporosis in woman to drive the demand for this application segment 87
TABLE 30 BONE DENSITOMETRY MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 88
6.7 PRENATAL GENETIC SCREENING & CARRIER TESTING 88
TABLE 31 PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 89
TABLE 32 PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 89
6.7.1 DOWN’S SYNDROME AND EDWARDS’ SYNDROME TESTING 90
6.7.1.1 Rising need for prenatal screening and easy availability of these tests to support market demand 90
TABLE 33 DOWN’S SYNDROME AND EDWARDS’ SYNDROME TESTING MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 90
6.7.2 TORCH TESTING 91
6.7.2.1 Various advantages of TORCH testing to drive the market demand 91
TABLE 34 TORCH TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 91
6.7.3 CF TESTING 91
6.7.3.1 Growing awareness about genetic disorders like cystic fibrosis to increase the demand for CF testing 91
TABLE 35 CF TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 92
6.7.4 OTHER PRENATAL GENETIC DISEASE TESTS 92
TABLE 36 OTHER PRENATAL GENETIC DISEASE TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 93
6.8 PREGNANCY & FERTILITY TESTING 93
TABLE 37 PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 94
TABLE 38 PREGNANCY & FERTILITY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 94
6.8.1 PREGNANCY TESTING & OVULATION PREDICTION KITS 95
6.8.1.1 Growing preference for confidentiality and accessibility of test results will drive market demand 95
TABLE 39 PREGNANCY TESTING & OVULATION PREDICTION KITS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 95
6.8.2 LAB-BASED TESTING 96
6.8.2.1 Increasing reliability of lab-based fertility tests to fuel market growth 96
TABLE 40 LAB-BASED TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 96
6.8.3 FERTILITY MONITORS 97
6.8.3.1 Fast and accurate data generation to increase the demand for fertility monitors 97
TABLE 41 FERTILITY MONITORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 97
6.9 ULTRASOUND TESTS 98
TABLE 42 ULTRASOUND TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 43 ULTRASOUND TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 98
6.9.1 OB/GYN IMAGING 99
6.9.1.1 Growing demand for minimally invasive techniques in gynecological applications to support market growth 99
TABLE 44 OB/GYN IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 99
6.9.2 BREAST IMAGING 100
6.9.2.1 Growing cases of breast cancer and the need for non-invasive procedures will drive the market demand for breast imaging 100
TABLE 45 BREAST IMAGING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 100
6.10 OVC TESTING 101
TABLE 46 OVC TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 101
TABLE 47 OVC TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 102
6.10.1 OVC TUMOR MARKER TESTS 102
6.10.1.1 Need for early diagnosis of OVC will drive the demand for advanced diagnostic devices 102
TABLE 48 OVC TUMOR MARKER TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 103
6.10.2 OVC DIAGNOSTIC IMAGING TESTS 103
6.10.2.1 Rising prevalence of women’s health-related disorders and growing awareness about various imaging tests to drive market growth 103
TABLE 49 OVC DIAGNOSTIC IMAGING TESTS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 104
6.10.3 OTHER OVC TESTS 104
TABLE 50 OTHER OVC TESTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 105

7 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER 106
7.1 INTRODUCTION 107
7.2 COVID-19 IMPACT ON THE WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER 107
TABLE 51 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 107
7.3 HOSPITALS & CLINICS 108
7.3.1 HOSPITALS & CLINICS ARE EXPECTED TO DOMINATE THE GLOBAL MARKET DURING THE FORECAST PERIOD 108
TABLE 52 WOMEN’S HEALTH DIAGNOSTICS MARKET FOR HOSPITALS & CLINICS,
BY COUNTRY, 2018–2025 (USD MILLION) 108
7.4 DIAGNOSTIC & IMAGING CENTERS 109
7.4.1 INCREASING NUMBER OF PRIVATE IMAGING CENTERS TO
DRIVE MARKET GROWTH 109
TABLE 53 WOMEN’S HEALTH DIAGNOSTICS MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2018–2025 (USD MILLION) 109
7.5 HOME CARE SETTINGS 110
7.5.1 INCREASING ADVANTAGES OF USING SELF-TESTING KITS TO DRIVE GROWTH IN THE MARKET 110
TABLE 54 WOMEN’S HEALTH DIAGNOSTICS MARKET FOR HOME CARE SETTINGS,
BY COUNTRY, 2018–2025 (USD MILLION) 110

8 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY REGION 111
8.1 INTRODUCTION 112
8.2 COVID-19 IMPACT ON VARIOUS REGIONS IN THE WOMEN’S HEALTH DIAGNOSTICS MARKET 112
FIGURE 17 WOMEN’S HEALTH DIAGNOSTICS MARKET: GEOGRAPHIC SNAPSHOT (2019) 113
TABLE 55 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY REGION, 2018–2025 (USD MILLION) 113
8.3 NORTH AMERICA 114
FIGURE 18 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SNAPSHOT 115
TABLE 56 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 115
TABLE 57 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET,
BY APPLICATION, 2018–2025 (USD MILLION) 116
TABLE 58 NORTH AMERICA: BREAST CANCER TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 116
TABLE 59 NORTH AMERICA: OSTEOPOROSIS TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 60 NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 117
TABLE 61 NORTH AMERICA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 117
TABLE 62 NORTH AMERICA: ULTRASOUND TESTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 63 NORTH AMERICA: STD TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 118
TABLE 64 NORTH AMERICA: PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 118
TABLE 65 NORTH AMERICA: CERVICAL CANCER TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 66 NORTH AMERICA: OVC TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 119
TABLE 67 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2018–2025 (USD MILLION) 119
8.3.1 US 120
8.3.1.1 The US dominates the North American women’s health diagnostics market 120
TABLE 68 US: WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 120
TABLE 69 US: BREAST CANCER TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 70 US: OSTEOPOROSIS TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 121
TABLE 71 US: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 121
TABLE 72 US: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 122
TABLE 73 US: ULTRASOUND TESTS MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 74 US: STD TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 122
TABLE 75 US: PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 76 US: CERVICAL CANCER TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 123
TABLE 77 US: OVC TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 123
TABLE 78 US: WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 124
8.3.2 CANADA 124
8.3.2.1 Surge in chronic lifestyle diseases and infectious diseases to support market growth in Canada 124
TABLE 79 CANADA: WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 124
TABLE 80 CANADA: BREAST CANCER TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 81 CANADA: OSTEOPOROSIS TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 82 CANADA: INFECTIOUS DISEASE TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 125
TABLE 83 CANADA: PREGNANCY & FERTILITY TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 84 CANADA: ULTRASOUND TESTS MARKET, BY TYPE,
2018–2025 (USD MILLION) 126
TABLE 85 CANADA: STD TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 126
TABLE 86 CANADA: PRENATAL GENETIC SCREENING & CARRIER TESTING MARKET,
BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 87 CANADA: CERVICAL CANCER TESTING MARKET, BY TYPE,
2018–2025 (USD MILLION) 127
TABLE 88 CANADA: OVC TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION) 127
TABLE 89 CANADA: WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER,
2018–2025 (USD MILLION) 128